Literature DB >> 19896421

Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase.

Kiranjit K Dhillon1, Julia M Sidorova, Tina M Albertson, Judith B Anderson, Warren C Ladiges, Peter S Rabinovitch, Bradley D Preston, Raymond J Monnat.   

Abstract

Werner syndrome (WS) is a human autosomal recessive genetic instability and cancer predisposition syndrome with features of premature aging. Several genetically determined mouse models of WS have been generated, however, none develops features of premature aging or an elevated risk of neoplasia unless additional genetic perturbations are introduced. In order to determine whether differences in cellular phenotype could explain the discrepant phenotypes of Wrn-/- mice and WRN-deficient humans, we compared the cellular phenotype of newly derived Wrn-/- mouse primary fibroblasts with previous analyses of primary and transformed fibroblasts from WS patients and with newly derived, WRN-depleted human primary fibroblasts. These analyses confirmed previously reported cellular phenotypes of WRN-mutant and WRN-deficient human fibroblasts, and demonstrated that the human WRN-deficient cellular phenotype can be detected in cells grown in 5% or in 20% oxygen. In contrast, we did not identify prominent cellular phenotypes present in WRN-deficient human cells in Wrn-/- mouse fibroblasts. Our results indicate that human and mouse fibroblasts have different functional requirements for WRN protein, and that the absence of a strong cellular phenotype may in part explain the failure of Wrn-/- mice to develop an organismal phenotype resembling Werner syndrome. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896421      PMCID: PMC2818259          DOI: 10.1016/j.dnarep.2009.09.013

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  91 in total

1.  Hyperinsulinemia and insulin resistance in Wrn null mice fed a diabetogenic diet.

Authors:  Gina Moore; Susan Knoblaugh; Kathryn Gollahon; Peter Rabinovitch; Warren Ladiges
Journal:  Mech Ageing Dev       Date:  2008-01-17       Impact factor: 5.432

2.  SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin.

Authors:  Eriko Michishita; Ronald A McCord; Elisabeth Berber; Mitomu Kioi; Hesed Padilla-Nash; Mara Damian; Peggie Cheung; Rika Kusumoto; Tiara L A Kawahara; J Carl Barrett; Howard Y Chang; Vilhelm A Bohr; Thomas Ried; Or Gozani; Katrin F Chua
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

3.  Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis.

Authors:  Ranga N Venkatesan; Piper M Treuting; Evan D Fuller; Robert E Goldsby; Thomas H Norwood; Ted A Gooley; Warren C Ladiges; Bradley D Preston; Lawrence A Loeb
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

4.  Role for the Werner syndrome protein in the promotion of tumor cell growth.

Authors:  Patricia L Opresko; José Palacios Calvo; Cayetano von Kobbe
Journal:  Mech Ageing Dev       Date:  2007-05-31       Impact factor: 5.432

5.  Flap endonuclease 1 contributes to telomere stability.

Authors:  Abhishek Saharia; Lionel Guittat; Sandra Crocker; Adeline Lim; Martin Steffen; Shashikant Kulkarni; Sheila A Stewart
Journal:  Curr Biol       Date:  2008-04-08       Impact factor: 10.834

6.  Werner protein cooperates with the XRCC4-DNA ligase IV complex in end-processing.

Authors:  Rika Kusumoto; Lala Dawut; Caterina Marchetti; Jae Wan Lee; Alessandro Vindigni; Dale Ramsden; Vilhelm A Bohr
Journal:  Biochemistry       Date:  2008-06-18       Impact factor: 3.162

7.  WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer.

Authors:  Takako Kawasaki; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Zhiqian Liu; Hiroyuki Yamamoto; Massimo Loda; Charles S Fuchs; Shuji Ogino
Journal:  Mod Pathol       Date:  2007-12-14       Impact factor: 7.842

Review 8.  Telomere ResQue and preservation--roles for the Werner syndrome protein and other RecQ helicases.

Authors:  Patricia L Opresko
Journal:  Mech Ageing Dev       Date:  2007-10-30       Impact factor: 5.432

9.  The RecQ helicase WRN is required for normal replication fork progression after DNA damage or replication fork arrest.

Authors:  Julia M Sidorova; Nianzhen Li; Albert Folch; Raymond J Monnat
Journal:  Cell Cycle       Date:  2008-01-04       Impact factor: 4.534

10.  Mechanism and substrate specificity of telomeric protein POT1 stimulation of the Werner syndrome helicase.

Authors:  Gregory Sowd; Ming Lei; Patricia L Opresko
Journal:  Nucleic Acids Res       Date:  2008-06-25       Impact factor: 16.971

View more
  6 in total

1.  Regulation of gene expression by the BLM helicase correlates with the presence of G-quadruplex DNA motifs.

Authors:  Giang Huong Nguyen; Weiliang Tang; Ana I Robles; Richard P Beyer; Lucas T Gray; Judith A Welsh; Aaron J Schetter; Kensuke Kumamoto; Xin Wei Wang; Ian D Hickson; Nancy Maizels; Raymond J Monnat; Curtis C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

2.  Uracil-DNA glycosylase in base excision repair and adaptive immunity: species differences between man and mouse.

Authors:  Berit Doseth; Torkild Visnes; Anders Wallenius; Ida Ericsson; Antonio Sarno; Henrik Sahlin Pettersen; Arnar Flatberg; Tara Catterall; Geir Slupphaug; Hans E Krokan; Bodil Kavli
Journal:  J Biol Chem       Date:  2011-03-23       Impact factor: 5.157

3.  Distinct functions of human RECQ helicases WRN and BLM in replication fork recovery and progression after hydroxyurea-induced stalling.

Authors:  Julia M Sidorova; Keffy Kehrli; Frances Mao; Raymond Monnat
Journal:  DNA Repair (Amst)       Date:  2012-12-17

4.  Application of the microfluidic-assisted replication track analysis to measure DNA repair in human and mouse cells.

Authors:  Piri Welcsh; Keffy Kehrli; Pavlo Lazarchuk; Warren Ladiges; Julia Sidorova
Journal:  Methods       Date:  2016-04-26       Impact factor: 3.608

5.  FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts.

Authors:  Erika Yeh; Rodrigo Atique; Felipe A A Ishiy; Roberto Dalto Fanganiello; Nivaldo Alonso; Hamilton Matushita; Katia Maria da Rocha; Maria Rita Passos-Bueno
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

6.  Mutator suppression and escape from replication error-induced extinction in yeast.

Authors:  Alan J Herr; Masanori Ogawa; Nicole A Lawrence; Lindsey N Williams; Julie M Eggington; Mallika Singh; Robert A Smith; Bradley D Preston
Journal:  PLoS Genet       Date:  2011-10-06       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.